Spot Trading L.L.C - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 189 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2014. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
Spot Trading L.L.C ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q4 2016$826,000
+24.8%
26,921
+218.8%
0.02%
+185.7%
Q4 2015$662,000
+21.5%
8,445
+16.8%
0.01%
+40.0%
Q3 2015$545,000
-65.5%
7,230
-46.5%
0.01%
-66.7%
Q2 2015$1,578,000
+397.8%
13,518
+908.8%
0.02%
+275.0%
Q1 2015$317,000
-79.8%
1,340
-83.9%
0.00%
-55.6%
Q4 2014$1,572,000
+238.1%
8,303
+18.0%
0.01%
+350.0%
Q2 2014$465,0007,0360.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2014
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 200,000$20,706,0006.01%
Redmile Group, LLC 230,673$23,882,0002.95%
WEATHERBIE CAPITAL, LLC 241,419$24,994,0002.31%
Tekla Capital Management LLC 185,820$19,238,0002.02%
Ghost Tree Capital, LLC 25,000$2,588,0001.59%
ADAGE CAPITAL PARTNERS GP, L.L.C. 5,686,668$588,741,0001.56%
Iguana Healthcare Management, LLC 25,000$2,588,0001.48%
Eventide Asset Management 42,100$4,359,0001.34%
Bain Capital Public Equity Management, LLC 401,330$41,550,0001.17%
Rock Springs Capital Management LP 31,500$3,261,0001.16%
View complete list of PUMA BIOTECHNOLOGY INC shareholders